These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-005111-24 Fluid therapy to patients reciving therapeutic hypothermia after cardiac arrest bad-data
Not reported 2006-002832-10 Liitännäishoitona annetun oksaliplatiinipohjaisen solusalpaajahoidon jälkeinen hedelmällisyys kolorektaalisyöpäpotilailla. Pohjoismainen prospektiivinen tutkimus. Fertility in colorectal cancer patien... 2015-12-31 due-trials
No trial status on register 2006-006469-17 A multicenter study to investigate the Sensitivity and Specificity of Aridol (Mannitol)Challenge as compared with Methacholine Challenge to predict a diagnosis of Asthma by a Specialist Pulmonologist ... bad-data
Not reported 2006-006616-30 Behandling med hyperton-kolloidal infusjon ved hjertekirurgi 2008-05-31 due-trials
Not reported 2009-010917-61 Glucocorticoid Replacement in Addison's disease 2012-12-06 due-trials
Listed as ongoing, but also has a completion date 2009-013094-17 A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral lenalidomide to standard induction therapy in AML and RAEB ≥ 66 years and v... 2023-12-31 bad-data
Listed as ongoing, but also has a completion date 2009-014455-68 A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral tosedostat to standard induction therapy in AML and RAEB ≥ 66 years and ver... 2023-12-31 bad-data
Reported results 2010-022307-22 The Bergen Psychosis Project 2 2017-12-20 due-trials
Completed, but no date 2010-023740-32 Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder bad-data
Exempt 2010-024289-24 TREATMENT OF PANCREATIC ADENOCARCINOMA BY COMBINING CONTRAST AGENT AND GEMCITABINE UNDER SONICATION not-yet-due
Completed, but no date 2011-002689-19 TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: DISEASE STABILIZATION THROUGH CHEMOTHERAPY, IMMUNOMODULATORY TREATMENT AND IMMUNOTHERAPY bad-data
Not reported 2011-005822-23 CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA 2017-02-20 due-trials
Completed, but no date 2012-000323-41 Randomised Trial of Contrast-enhanced Sonothrombolysis in acute ischaemic stroke bad-data
Completed, but no date Terminated 2012-001020-35 A randomized phase II trial comparing bevacizumab monotherapy with dacarbazine (DTIC) in treatment of malignant melanoma, focusing on angiogenic markers and prevention of hypertension. bad-data
Completed, but no date Terminated 2012-001175-36 LOW-DOSE KETAMINE AS ADJUVANT TREATMENT TO MORPHINE IN NEUROPATHIC CANCER PAIN. bad-data
Other 2013-002363-26 Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer not-yet-due
Reported results 2013-002524-16 Everolimus and temozolomide as first-line treatment in advanced gastrointestinal neuroendocrine carcinoma (G3) with a Ki67 of 20-55% 2019-12-01 due-trials
Completed, but no date 2013-004189-33 ULTRADIAN SUBCUTANEOUS HYDROCORTISONE (USHI) INFUSION IN ADDISON’S DISEASE bad-data
Exempt 2014-000302-34 Ipratropium bromide ved anstrengelsesutløst laryngeal obstruksjon (EILO - Exercise Induced Laryngeal Obstruction). not-yet-due
Reported results 2014-004029-41 Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An open label phase-II study with 6 infusions of cyclophosphamide 4 weeks apart. Cyclofosfamid ved myalgisk encefalopati/kron... 2020-06-25 due-trials
Exempt 2015-002615-15 A Phase Ib/II randomised open label study of BGB324 in combination with pembrolizumab or dabrafenib/trametinib compared to pembrolizumab or dabrafenib/trametinib alone, in patients with advanced non-r... 2024-05-23 not-yet-due
Other 2015-002816-34 PErsonalized TREatment of high-risk MAmmary Cancer - the PETREMAC trial not-yet-due
Other 2016-003459-31 Treatment of patients with advanced breast cancer harboring TP53 mutations with dose-dense cyclophosphamide - the p53 trial Behandling av pasienter med metastatisk brystkreft med TP53 mutasjoner me... not-yet-due
Not reported Terminated 2017-000163-32 The Norwegian Prednisolone in Early Psychosis Study - NorPEPS The role of immune-modulating strategies in the treatment of psychosis 2022-01-25 due-trials
Other 2017-001362-25 Randomized autologous hematopoietic stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab for patients with relapsing remitting Multiple Sclerosis not-yet-due
Other 2017-001690-16 Bortezomib sensitization of recurrent glioblastoma with unmethylated MGMT promoter to Temozolomide phase 1B/II study not-yet-due
Not reported Terminated 2018-003090-95 The Norwegian Tenecteplase Stroke Trial 2 ( NOR-TEST 2 ) Tenecteplase in Acute Stroke 2 2023-08-25 due-trials
Other 2019-003735-28 The role of sonoporation-enhanced treatment with Gemcitabine, Nab-Paclitaxel and FOLFIRINOX in patients with inoperable pancreatic cancer. not-yet-due
Other 2020-001205-23 Ocrelizumab VErsus Rituximab off-Label at the Onset of Relapsing MS Disease (OVERLORD-MS) not-yet-due
Other 2020-002373-95 Study of Mesenchymal Autologous stem cells as Regenerative Treatment for Multiple Sclerosis not-yet-due
Other 2021-000641-41 PROSPECTIVE COMPARISON OF SIROLIMUS AGAINST CORTICOSTEROIDS IN TREATMENT OF PATIENTS WITH ACTIVE THYROID EYE DISEASE not-yet-due
Other 2021-002284-22 Hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomized controlled trial not-yet-due
Completed, but no date 2021-003804-42 Immunogenicity, molecular profiling and safety of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra) administered by the intramuscular route in children 3-11 years old bad-data
Not reported Terminated 2021-004417-40 The effect of pregabalin in the treatment of acute post-operative peripheral neuropathic pain – a pilot study 2024-03-01 due-trials
Other 2021-004452-42 An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabolic control in antipsychotic-using patients (STABIL-NOR – st... not-yet-due
Other 2021-004981-37 Benzodiazepine maintenance treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR) not-yet-due
Other 2021-006487-24 A registry-based, open-label, randomized study to investigate quality-of-life with Plenadren compared with Cortison in participants aged 16-80 with newly diagnosed primary adrenal insufficiency not-yet-due
Other 2022-000281-18 A pilot study using subcutaneous injections of the anti-CD38 antibody daratumumab in six patients with moderate to severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Resetting the humoral immu... not-yet-due
Completed, but no date 2022-001710-19 Sonographic diagnostics with oral contrast for Crohns. A novel method for detecting Crohns disease using sonographic intraluminal contrast. bad-data
Other 2022-002241-18 Diagnostic treatment-trial for autonomous cortisol secretion- a tool to select patients for adrenalectomy not-yet-due
Other 2022-003244-27 PAxlovid loNg cOvid-19 pRevention triAl with recruitMent In the Community in Norwayy not-yet-due